Clinical Efficacy
In male and female patients, the incidence of appropriate shocks was comparable, but with a higher tendency in females. In 1998, Auricchio et al. presented successfully arrhythmia detection and defibrillation in 9 patients out of 10[22]. Other randomized trials showed the safety and efficacy of WCD in the termination of VT/VF. In this regard, first shock success was in 79 of 80 (99%) among all patients from whom were 74% male participants, respectively [23].